Slocum, Gordon & CO LLP Baxter International Inc Transaction History

Slocum, Gordon & CO LLP

  • $512 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$37.32 - $49.29 $18,660 - $24,645
-500 Reduced 7.69%
6,005 $226,000
Q2 2023

Oct 23, 2023
BUY
$39.98 - $47.68 $260,069 - $310,158
6,505 New
6,505 $296,000
Q1 2023

Dec 14, 2023
BUY
$37.58 - $52.57 $24,427 - $34,170
650 Added 10.82%
6,655 $269,000
Q4 2022

Dec 06, 2023
BUY
$49.7 - $57.71 $1.04 Million - $1.21 Million
20,950 Added 348.88%
26,955 $1.37 Billion

Others Institutions Holding BAX

# of Institutions
1,007
Shares Held
450M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Slocum, Gordon & CO LLP Portfolio

Follow Slocum, Gordon & CO LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slocum, Gordon & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Slocum, Gordon & CO LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email